trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['breast', 'bcsm', 'destiny,breast,2', 'destiny,breast,4', 'trastuzumab deruxtecan']
destiny-breast04 update showcases qol benefit with trastuzumab deruxtecan for hr+, her2-low breast cancer #bcsm #esmo2022 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.